Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Puma Biotechnology (PBYI) Return on Equity (2018 - 2025)

Historic Return on Equity for Puma Biotechnology (PBYI) over the last 9 years, with Q3 2025 value amounting to 0.27%.

  • Puma Biotechnology's Return on Equity fell 1200.0% to 0.27% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.27%, marking a year-over-year decrease of 1200.0%. This contributed to the annual value of 0.32% for FY2024, which is 2600.0% down from last year.
  • Puma Biotechnology's Return on Equity amounted to 0.27% in Q3 2025, which was down 1200.0% from 0.41% recorded in Q2 2025.
  • Over the past 5 years, Puma Biotechnology's Return on Equity peaked at 4.34% during Q4 2021, and registered a low of 20.84% during Q1 2022.
  • In the last 5 years, Puma Biotechnology's Return on Equity had a median value of 0.2% in 2023 and averaged 1.45%.
  • Per our database at Business Quant, Puma Biotechnology's Return on Equity plummeted by -157800bps in 2022 and then skyrocketed by 210400bps in 2023.
  • Puma Biotechnology's Return on Equity (Quarter) stood at 4.34% in 2021, then tumbled by -100bps to 0.0% in 2022, then surged by 512401bps to 0.47% in 2023, then tumbled by -39bps to 0.28% in 2024, then decreased by -4bps to 0.27% in 2025.
  • Its Return on Equity was 0.27% in Q3 2025, compared to 0.41% in Q2 2025 and 0.33% in Q1 2025.